{"product_id":"nras-antibody-sc-f0709","title":"Ras (G12D Mutant Specific) Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eNRAS is a target of interest in many antibody-based workflows. RAS proteins function as binary molecular switches, alternating between an active state bound to guanosine triphosphate (GTP) and an inactive state bound to guanosine diphosphate (GDP). This switch mechanism is conserved across various GDP\/GTP binding proteins, including bacterial elongation factors, heterotrimeric G-proteins, and numerous small GTPases with diverse biological roles. Depending on the literature source, NRAS may also be discussed as Ras (G12D Mutant Specific) and HRas.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell membrane, golgi apparatus, membrane, and nucleus, which can matter when signal is compared across treatments or changing cell states. Following NRAS across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state. In practice, this target is often considered at the family or isoform-group level, so experimental interpretation benefits from matched controls and clear comparison logic.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eNRAS is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, golgi apparatus, and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell membrane, golgi apparatus, and membrane across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003esignal-dependent shifts after ligand, inhibitor, or growth-factor perturbation\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for NRAS. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in NRAS reflect biology rather than handling. When interpreting NRAS, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep NRAS trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577505980761,"sku":"F0709-20UL","price":219.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577506013529,"sku":"F0709-100UL","price":449.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577506046297,"sku":"F0709-2X100UL","price":669.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F0709-wb.gif?v=1773598822","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/nras-antibody-sc-f0709","provider":"Absource Diagnostics","version":"1.0","type":"link"}